Form 4 Tracker
Disc Medicine, Inc.
IRON

34 insider filings · Latest: Aug 12, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jul 23, 2025Jul 23 8:25 PMAtlas Venture Fund X, L.P.
Proposed Sale
53,215$60.74$3.2M

View →

Jul 18, 2025Jul 18 8:33 PMAtlas Venture Opportunity Fund I, L.P.
Proposed Sale
664$57.79$38.4K

View →

Jul 18, 2025Jul 18 8:31 PMAtlas Venture Fund X, L.P.
Proposed Sale
1,184$57.79$68.4K

View →

Jul 17, 2025Jul 17 8:20 PMJEAN FRANCHI
Proposed Sale
2,031$57.34$116.5K

View →

Jul 10, 2025Jul 10 8:34 PMJEAN FRANCHI
Proposed Sale
2,000$55.86$111.7K

View →

Jul 9, 2025Jul 9 8:17 PMJOHN QUISEL
Proposed Sale
34,800$52.97$1.8M

View →

Jul 3, 2025Jul 3 5:30 PMJOHN QUISEL
Proposed Sale
5,200$53.17$276.5K

View →

Jun 16, 2025Jun 16 8:22 PMJEAN FRANCHI
Proposed Sale
2,000$53.71$107.4K

View →

Jun 6, 2025Jun 6 8:25 PMWILLIAM SAVAGE
Proposed Sale
2,996$48.01$143.8K

View →

May 2, 2025May 2 8:22 PMWILLIAM SAVAGE
Proposed Sale
8,777$49.68$436.0K

View →

Mar 10, 2025Mar 10 10:46 PMOrbiMed Genesis Master Fund, L.P.
Proposed Sale
74,800$55.67$4.2M

View →

Mar 10, 2025Mar 10 10:45 PMOrbiMed Private Investments VI, LP
Proposed Sale
193,400$55.67$10.8M

View →

Mar 10, 2025Mar 10 10:44 PMOrbiMed Private Investments VIII, LP
Proposed Sale
299,200$55.67$16.7M

View →

Feb 5, 2025Feb 5 9:05 PMAtlas Venture Fund X, L.P.
Proposed Sale
112,211$54.32$6.1M

View →

Feb 4, 2025Feb 4 10:14 PMAtlas Venture Fund X, L.P.
Proposed Sale
6,350$54.99$349.2K

View →

Feb 3, 2025Feb 3 9:28 PMAtlas Venture Fund X, L.P.
Proposed Sale
6,439$55.80$359.3K

View →

Jan 2, 2025Jan 2 9:20 PMRAHUL KHARA
Proposed Sale
15,000$63.40$951.0K

View →

Dec 30, 2024Dec 30 9:11 PMJOHN QUISEL
Proposed Sale
13,012$64.12$834.3K

View →

Dec 23, 2024Dec 23 9:21 PMJOHN QUISEL
Proposed Sale
19,820$64.50$1.3M

View →

Dec 16, 2024Dec 16 9:39 PMJOHN QUISEL
Proposed Sale
12,791$64.89$830.0K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Aug 12, 2026Aug 14 11:14 PMJonathan Yen-Wen YuChief Operating Officer
Option Exercise
804$13.5022,943(D)

View →

Aug 6, 2026Aug 7 9:32 PMRahul KharaChief Legal Officer
Option Exercise
5,000$14.6949,804(D)

View →

Jul 13, 2026Jul 14 10:32 PMJohn D QuiselDirector, Chief Executive Officer
Option Exercise
33,000$13.50124,586(D)

View →

Jul 7, 2026Jul 9 11:35 PMJonathan Yen-Wen YuChief Operating Officer
Option Exercise
100$13.5023,747(D)

View →

Jun 29, 2026Jun 30 9:49 PMRahul KharaChief Legal Officer
Option Exercise
1,649$14.6954,804(D)

View →

Jun 26, 2026Jun 30 9:49 PMRahul KharaChief Legal Officer
Option Exercise
851$14.6956,453(D)

View →

Jun 26, 2026Jun 30 9:45 PMJonathan Yen-Wen YuChief Operating Officer
Option Exercise
300$13.5023,847(D)

View →

Jun 22, 2026Jun 25 12:34 AMJonathan Yen-Wen YuChief Operating Officer
Option Exercise
9,700$13.5024,147(D)

View →

Jun 18, 2026Jun 23 9:21 PMRahul KharaChief Legal Officer
Option Exercise
7,500$14.6957,304(D)

View →

Jun 18, 2026Jun 23 9:16 PMJohn D QuiselDirector, Chief Executive Officer
Option Exercise
34,000$9.8641,375(D)

View →

Jun 18, 2026Jun 23 9:04 PMWilliam Richard WhiteDirector
Grant/Award
6,212$70.796,212(D)

View →

Jun 18, 2026Jun 23 9:01 PMLiam RatcliffeDirector
Grant/Award
6,212$70.796,212(D)

View →

Jun 18, 2026Jun 23 9:00 PMDonald William NicholsonDirector
Grant/Award
6,212$70.796,212(D)

View →

Jun 18, 2026Jun 23 8:59 PMGeorges GemayelDirector
Grant/Award
6,212$70.796,212(D)

View →

Jun 18, 2026Jun 23 8:58 PMMark ChinDirector
Grant/Award
6,212$70.796,212(D)

View →

Jun 18, 2026Jun 23 8:56 PMKevin BittermanDirector
Grant/Award
6,212$70.796,212(D)

View →

Jun 18, 2026Jun 23 8:54 PMNadim AhmedDirector
Grant/Award
5,176$70.795,176(D)

View →

Jun 16, 2026Jun 18 8:43 PMJonathan Yen-Wen YuChief Operating Officer
Option Exercise
18,612$9.8631,951(D)

View →

Feb 10, 2026Feb 12 12:50 AMRahul KharaChief Legal Officer
Grant/Award
25,500$74.7525,500(D)

View →

Feb 10, 2026Feb 12 12:46 AMPamela StephensonChief Commercial Officer
Grant/Award
25,500$74.7525,500(D)

View →

Page 1 of 2

Next →